Clinical trial
Clinical Studies of Gemcitabine-Oxaliplatin
NCT00407433 · Gustave Roussy, Cancer Campus, Grand Paris, Other · Completed
Key facts
| NCT number | NCT00407433 |
|---|---|
| Title | Clinical Studies of Gemcitabine-Oxaliplatin |
| Official title | Phase 2 Single-Arm Studies of Gemcitabine in Combination With Oxaliplatin Refractory and Relapsed Pediatric Solid Tumors |
| Lead sponsor | Gustave Roussy, Cancer Campus, Grand Paris, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Medulloblastoma, Central Nervous System Tumors, Neuroblastoma, Osteosarcoma |
| Intervention type | Drug |
| Interventions | Gemcitabine (Gemzar®), Oxaliplatin (Eloxatin®) |
| Enrollment | 156 |
| First posted | Dec 5, 2006 |
| Last update posted | Aug 7, 2009 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: